Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate

Respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (HPIV3) are the first and second leading viral agents of severe respiratory tract disease in infants and young children worldwide. Vaccines are not available, and an RSV vaccine is particularly needed. A live attenuated chimeric...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Virol
Hauptverfasser: Liang, Bo, Surman, Sonja, Amaro-Carambot, Emerito, Kabatova, Barbora, Mackow, Natalie, Lingemann, Matthias, Yang, Lijuan, McLellan, Jason S., Graham, Barney S., Kwong, Peter D., Schaap-Nutt, Anne, Collins, Peter L., Munir, Shirin
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2015
Schlagworte:
Vaccines and Antiviral Agents
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4542370/
https://ncbi.nlm.nih.gov/pubmed/26157122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01373-15
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge